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Abstract
Background: The effects of fish consumption and n-3 fatty acids on type 2 diabetes mellitus (T2DM) have recently been
debated.
Objective:We explored the risk of T2DM in relation to consumption of lean fish, fatty fish, fish products and total fish as well
as cod liver oil supplements in a representative sample of Norwegian women.
Design: This was a prospective population based cohort study in 33740 women free of T2DM, stroke, angina or heart attack
and with detailed information on important co-variates and dietary intake at baseline. Risk ratios and corresponding 95% CI
were estimated using Poisson regression with log-person time as offset.
Results: Lean fish consumption was inversely associated with T2DM compared to zero intake. Risk ratios and 95% CI for
intake of 75 and 100 g lean fish per day were 0.71 (0.51, 0.98) and 0.67 (0.46, 0.98), respectively. There was no effect of
intake of fatty fish, fish products, total fish or use of cod liver oil supplements on the risk of T2DM.
Conclusion: Lean fish consumption of 75–100 g/d had a beneficial effect on T2DM. It remains unclear whether lean fish in
itself has a protective effect on T2DM or that lean fish consumers have a protective life-style that we were not able to take
into account in this study. Unfavorable effects of fatty fish consumption or use of cod liver oil supplements on T2DM were
not observed.
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Introduction
Type 2 diabetes mellitus (T2DM) is increasing in epidemic
proportions worldwide and is becoming a global health challenge.
In 1980, approximately 153 million people had diabetes and by
2008, that number was more than doubled [1]. It has been
estimated that the global burden of diabetes will further increase to
more than 550 million by 2030 [2], thus, prevention of the disease
is of great public health interest.
Even though the causes of T2DM are not fully understood, a
number of risk factors are well known and include among others:
overweight and obesity, family history of diabetes, age, impaired
glucose tolerance, sedentary lifestyle, hypertension and history of
gestational diabetes. As T2DM is closely linked to overweight and
obesity, there has been an increasing focus on the effect of different
diets on the prevention and management of T2DM [3]. T2DM
and cardiovascular diseases (CVD) have many of the same risk
factors in common. Since consumption of fatty fish that contain
long chain n-3 fatty acids has showed beneficial effects on the risk
of CVD as well as on blood lipids profiles [4], one could expect fish
consumption reducing the risk of T2DM as well. Recently, a
number of prospective studies have explored associations between
fish consumption and risk of T2DM, with conflicting findings [5–
8]. One limitation of some of these studies has been the lack of
distinction between fatty and lean fish. Several systematic reviews
and meta-studies have concluded that there are indications of
geographical differences in observed effects of fish consumption,
with studies from Asia showing a protective effect whereas studies
from North America/Europe indicating an increased risk of
T2DM with fish consumption [9,10]. In contrary, a recent nested
case-cohort study across eight European countries concluded no
effect of total fish consumption on T2DM and indicated a
protective effect of fatty fish consumption on the development of
T2DM [11].
Fish, and particularly lean fish, is a major part of the Norwegian
diet, especially for people living along the Norwegian coastline.
Age-adjusted mean intake of total fish was 63 g/day for women
residing along in the north or the west coast of Norway [12]. For
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women living in southeast Norway the corresponding number
were 42 g/d. Even though there are geographical differences,
Norwegian middle-aged women consume almost twice as much
fish as women in the other Scandinavian countries and almost five
times as much as women from the Netherlands [12]. The
Norwegian Directorate of Health recommends people in general,
and young people particular, to consume at least two servings of
fish per week. A large proportion (45%) of Norwegian middle-aged
women also uses cod liver oil as dietary supplements regularly
[13]. Cod liver oil supplements, as well as fatty fish, contain long-
chain n-3 fatty acids. A number of clinical trials have addressed the
relationship between long chained n-3 fatty acids and the glucose
metabolism. Some have indicated reduced insulin sensitivity
among obese or diabetic subjects after treatment with n-3
supplements [14,15], however a recent meta-analysis of 11 clinical
trials concluded no effect [16].
As Norwegian women have a high intake of fish as well as a
regular use of n-3 supplements, this study was conducted to
explore the risk of T2DM in relation consumption of lean fish,
fatty fish, processed fish products, total fish and cod liver oil
supplements.
Subjects and Methods
The Norwegian Woman and Cancer Study
The Norwegian Women and Cancer Study (NOWAC) is a
national representative cohort study that was initiated in 1991 with
the aim of exploring associations between lifestyle and cancer
among Norwegian women. Detailed information about study
design, population and procedures has been described elsewhere
[17]. The external validity of NOWAC has also been thoroughly
validated [18]. Currently, more than 170 000 Norwegian women
aged 30–70 years have been enrolled in the study. All participants
have answered one to four questionnaires about their current
health status and different lifestyle habits, including diet. The
questionnaires have been distributed in series and the questions in
the different series have varied depending on age group and
hypothesis tested; however, some questions have been common in
Table 1. Self-reported baseline characteristics of the total study population (n = 33740), the incident diabetes cases (n = 479) and
the non-diabetic subjects (n = 33261).
Total (n = 33740) Diabetes cases (n=479)
Non-diabetic subjects
(n =33261) p-valuea
Age (years) Mean age at enrollment 47.9 48.7 47.9 2.3e-6
Min-max 40–55 40–55 40–55
Energy intake (kcal/d) Mean 1683 1668 1683 3.9e-1
Median 1657 1619 1657
Min-Max 676–3632 774–3082 676–3632
Carbohydrates (g/d) Mean 197 192 197 2.0e-2
Median 194 186 194
Min-Max 37.8–420 74.4–381 37.8–420
Saturated fat (g/d) Mean 25.8 25.5 25.8 2.9e-1
Median 24.7 24.0 24.7
Min-Max 1.05–90.3 4.8–57.2 1.05–90.3
BMI (%) ,25 65.0 21.9 65.7 2.2e-16
25–30 27.3 36.4 27.2
.30 7.6 34.9 7.2
Years of education (%)b ,10 20.4 27.2 20.3 1.5e-5
10–12 24.4 28.0 24.3
.12 55.2 44.8 55.4
Physical activity (%) Low 12.0 22.5 11.9 8.0e-12
Moderate 75.1 67.2 75.2
High 12.9 10.2 12.9
Smoking status (%) Never 37.7 32.1 37.8 4.0e-2
Former 31.4 33.8 31.4
Current 31.9 34.0 30.8
Hypertension (%) No 90.5 71.4 90.7 2.2e-16
Yes 9.5 28.6 9.3
Alcohol consumption (%) 0 g/d 18.6 27.6 18.4 4.4e-7
1–50 g/d 40.0 40.5 40.0
50–100 g/d 29.1 23.4 29.2
.100 g/d 12.3 10.8 12.4
aThe p-value refers to the difference between diabetic and non-diabetic individuals.
bMissing information on education, n = 1148.
doi:10.1371/journal.pone.0089845.t001
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all series. Between 2003 and 2007, approximately 50 000 of the
NOWAC participants also donated a blood sample. The latter
constitute the NOWAC postgenome cohort [19].
Ethics Statement
The NOWAC study was approved by the Regional Committee
for Medical Research Ethics and the Norwegian Data Inspector-
ate. All participants gave written informed consent.
NOWAC Food Frequency Questionnaire
The majority of the NOWAC questionnaires contain detailed
questions on dietary habits. The participants were asked to record
how often they consumed more than 90 different foodstuffs during
the preceding year. Information about portion size was also
included. The food frequency questionnaire (FFQ) has special
emphasis on fish consumption. The NOWAC FFQ has been
thoroughly validated by 24 h recalls [20], a test-retest study [21]
and against serum phospholipid fatty acid composition as
biomarkers of fish consumption [22]. The validation studies
showed that the NOWAC FFQ has good ability to rank subjects
according to food eaten frequently. The reproducibility of the
NOWAC FFQ was in the same range as similar instruments. The
validation study on fish consumption underlined the importance of
distinction between fatty and lean fish and the inclusion of portion
sizes in order to achieve high quality data.
Table 2. Crude risk ratios (RR) with 95% confidence intervals (95% CI) and age-adjusted RR (95% CI) of T2DM in relation to a
number of co-variates and exposure variables.
RR crude (95% CI) p-value RRage-adjusted (95% CI) p-value
Age (years) 1.04 (1.02, 1.06) 1.2e-4 – –
BMI (kg/m2)
,25 (n = 21946) 1.00 1.00
25–30 (n = 9222) 4.38 (3.45, 5.55) ,2e-16 4.31 (3.40, 5.47) ,2.0e-16
.30 (n = 2572) 15.4 (12.1, 19.6) ,2e-16 15.2 (11.9, 19.3) ,2.0e-16
Physical activity
Low (n = 4065) 1.00 1.00
Medium (n = 25326) 0.47 (0.38, 0.59) 1.5e-11 0.48 (0.39, 0.60) 4.7e-11
High (n = 4349) 0.42 (0.30, 0.59) 4.3e-7 0.43 (0.31, 0.60) 9.2e-7
Hypertension
No (n = 30520) 1.00 1.00
Yes (n = 3220) 3.89 (3.19, 4.74) ,2e-16 3.74 (3.06, 4.57) ,2.0e-16
Smoking status
Never (n = 12720) 1.00 1.00
Former (n = 10603) 1.27 (1.02, 1.59) 3.0e-2 1.30 (1.04, 1.62) 2.0e-2
Current (n = 10417) 1.31 (1.05, 1.63) 2.0e-2 1.35 (1.08, 1.68) 8.0e-3
Education (years)
,10 (n = 6652) 1.00 1.00
10–12 (n = 7948) 0.85 (0.67, 1.09) 2.0e-1 0.88 (0.69, 1.13) 3.2e-1
.12 (n = 17992) 0.60 (0.48, 0.75) 5.6e-6 0.63 (0.51, 0.79) 6.5e-5
Alcohol consumption (g/d)
0 (n = 6257) 1.00 1.00
,50 (n = 13507) 0.68 (0.54, 0.85) 6.0e-4 0.69 (0.55, 0.86) 1.1e-3
51–100 (n = 9817) 0.53 (0.41, 0.69) 9.4e-7 0.54 (0.42, 0.70) 2.2e-6
.100 (n = 4159) 0.46 (0.32, 0.65) 1.2e-5 0.47 (0.33, 0.67) 2.4e-5
Cod liver oil supplements
No (n = 18072) 1.00 1.00
Yes (n = 14763) 0.77 (0.64, 0.93) 6.8e-3 1.04 (1.02, 1.07) 3.4e-3
Carbohydrates (per 50 g/d) 0.89 (0.82, 0.98) 1.2e-2 0.90 (0.82, 0.98) 1.8e-2
Saturated fat(per 10 g/d) 0.96 (0.86, 1.06) 3.9e-1 0.97 (0.87, 1.07) 5.3e-1
Total energy intake (per 500 kcal) 0.95 (0.85, 1.06) 3.4e-1 0.96 (0.86, 1.07) 4.5e-1
Lean fish (per 25 g/d) 1.02 (0.95, 1.11) 5.7e-1 1.01 (0.93, 1.10) 7.9e-1
Fatty fish (per 25 g/d) 1.13 (1.01, 1.28) 4.0e-2 1.11 (0.99, 1.25) 7.8e-2
Fish products (per 25 g/d) 1.04 (0.95, 1.13) 4.1e-1 1.04 (0.96, 1.13) 3.6e-1
Total fish (per 25 g/d) 1.04 (1.00, 1.09) 2.8e-2 1.04 (1.00, 1.08) 5.1e-2
doi:10.1371/journal.pone.0089845.t002
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Cross-sectional Validation of Self-reported Diabetes
In the NOWAC questionnaire, the participants are asked if they
have diabetes (yes/no) and at what age they got the diagnosis.
There is no distinction between different types of diabetes. In
order to ensure proper endpoints, we conducted a cross-sectional
validation study of self-reported diabetes based on information
from 47603 subjects. Between 2002 and 2007, these subjects
answered their second or third questionnaire. Some of them also
donated a blood sample. Criteria for being included in the
validation study were a positive answer on self-reported diabetes.
In total 1066 (2.2%) women reported having diabetes, of which a
random sample of 400 subjects was drawn. Of the randomly
selected 400 subjects, 226 (56.5%) had donated a blood sample.
The 400 study subjects were identified by Statistics Norway and
we were provided with full name and home address to the
participants. Twenty-one women were either diseased or emigrat-
ed; therefore, the total number included in the validation study
was 379.
The 379 subjects were invited to participate in the study
through an invitational letter sent to their home address. The
participants were asked to confirm their diabetes diagnosis. They
were also asked what year they got their diagnosis and how they
were treated for the disease. Additionally, we asked for permission
to contact their general physician (GP) in order to confirm what
type of diabetes the participants had (type 1, type 2 or other).
The GPs were contacted through a letter to their office where
we asked for confirmation of the diabetes diagnosis, as well as year
of diagnosis and type of diabetes. The validation study was
approved by the Regional Committee for Medical Research
Ethics.
Among the 379 subjects included in the validation study, the
total response rate was 58%, corresponding to 217 subjects. Blood
donors were more likely to respond (65%) than the non-donors
(47%). Among the 211 subjects willing to participate in the study,
177 (84%) confirmed having T2DM. The remaining 34 subjects
(16%) reported either T1DM (7.5%), gestational diabetes (1.4%),
Mody 3 (0.5%) or other diagnosis (0.5%). Thirteen subjects (6.1%)
claimed never having any form of DM. Thus, the positive
predictive value (PPV) of the questionnaire in regards to T2DM
was 84%. PPV for all forms of diabetes was 93%. Excluding those
refuting having diabetes showed that 89.4% of all diabetes cases
were T2DM. Self-reported mean age at time for diagnosis for
confirmed T2DM cases were 48 years (min-max: 36–61 years).
For those subjects claiming having T1DM, the self-reported mean
age at time for diagnosis were 44 years (min-max: 35–57 years).
Only subjects confirming their T2DM diagnosis allowed us to
contact their GP. The response rate among GPs was 82%. The
GPs confirmed T2DM in 141 of 146 cases and disproved the
diagnosis for five subjects. Thus, PPV of the second confirmation
from the subjects was 97%.
Of the 177 women confirming their diabetes diagnosis, 39 had
missing information on self-reported diabetes at their previous
questionnaire. Of these 39, we received information about the year
of diagnosis from 30 GPs. When comparing year of diagnosis to
Figure 1. Risk ratios (RR) and 95% CI of T2DM by lean fish consumption. RRs are indicated by the solid line and the 95% CI by the dashed
horizontal lines. Numbers are adjusted for BMI, hypertension, smoking status, age and physical activity. Median intake of lean fish in the study group
is indicated by the dashed vertical line.
doi:10.1371/journal.pone.0089845.g001
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date of baseline questionnaire, we found that 25 (83.3%) were
incident cases, i.e., missing information on self-reported diabetes
was equal to ‘‘No’’. For 1 (3.3%) subject, year of diagnosis were
prior to date of first questionnaire and for the remaining four
(13.3%) subjects, it was unclear as year of diagnosis and date of
first questionnaire were less than six months apart.
The Prospective Analysis of Fish Consumption and Risk of
Type 2 Diabetes
Study population. A total of 48232 women were included in
the prospective analysis of fish consumption and risk of T2DM.
The study subjects answered the baseline questionnaire between
1996 and 1998. Between 2002 and 2005, the subjects were
followed-up with a repeated questionnaire, thus follow-up time
were defined by date of questionnaire at baseline and date of
questionnaire at follow-up. As we had no valid confirmation of
date of diagnosis for the cases, their follow-up time was defined as
half the time between the two questionnaires.
At baseline, there were 542 self-reported prevalent cases of
diabetes, which were excluded from further analyses. In addition,
2132 women were excluded as they were not asked dietary
questions at baseline and 86 subjects that were not asked questions
on disease history. We made further exclusions for baseline missing
information on key co-variates including body mass index (BMI,
n = 738), physical activity (n = 2739) and smoking (n = 1620). We
further restricted the analyses to only those with a certain detailed
dietary questionnaire at baseline (n = 34845). Subjects being in the
top 1% or bottom 1% of the ratio of total daily energy intake and
basal metabolic rate (calculated from weight, height and age at
baseline) were excluded (n = 698). We further excluded subjects
with history of stroke, angina or heart attack (n = 407). There were
4811 subjects with missing information on hypertension (yes/no).
Including their missing answers as negative answers did not
change the effect estimates substantially, and thus they were
included in the analysis. In total, 33740 subjects were included in
the prospective analyses.
Exposure variables. Daily intake (g/day) of fatty fish, lean
fish, processed fish products, total fish and use of cod liver oil
supplements were explored. Fatty fish included salmon, trout,
herring, mackerel, wolffish, redfish and flounder whereas lean fish
comprised cod, saithe, pollock and haddock. Fish products
included fish fingers (coated in bread crumbles), minced fish
products (fish cakes, fish balls etc.) and fish au gratin. These are
mainly made from lean fish and contain on average 30–50% fish.
Even though fish products contain lean fish, this variable was
evaluated separately since it consists of a large proportion of flour,
milk and fat as well. Total fish included fatty fish, lean fish, fish
products, preserved fish for bread, fish liver, fish roe and
crustaceans. Use of cod liver oil supplements was assembled into
two categories (yes/no).
End-point. Of the 33740 subjects included in the prospective
analyses, there were 479 reported incident cases of diabetes at
follow-up. However, only 335 of these subjects had a negative
answer on diabetes at baseline and a positive at follow-up. The
Figure 2. Risk ratios (RR) and 95% CI by fatty fish consumption. RRs are indicated by the solid line and the 95% CI by the dashed horizontal
lines. Numbers are adjusted for BMI, hypertension, smoking status, age and physical activity. Median intake of fatty fish in the study group is
indicated by the dashed vertical line.
doi:10.1371/journal.pone.0089845.g002
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remaining 144 subjects had missing answers on the diabetes
question at baseline and a positive answer at follow-up. For the
prospective analyses, missing information on diabetes were
interpreted as a negative answer, thus, 479 cases were included
in the study. The cases are hereafter referred to as T2DM cases.
Statistical Methods
The freely available statistical software R (version 3.0.0) with the
packages Epi, splines and survival was used for the statistical
analyses (http://www.cran.r-project.org). Differences in baseline
characteristics between diabetes cases and the non-diabetic
subjects were evaluated using analyses of variance and chi square
test. Risk ratios and their corresponding 95% CI were estimated
using Poisson regression with the log-person time as offset and the
use of natural splines with 4 degrees of freedom for the exposure
variables of interest. When Poisson regression is used for modeling
rates, the logarithm of the time unit (here person-years) is added to
the model as a fixed variable to take into account the various
person-time of the study subject. This is called an ‘‘offset’’. Natural
splines split the exposure variables into segments and fit a cubic
function for each segment. Within each segment, the function is
estimated to be constant. By extracting the knots (the cut-off values
between segments) and the boundary knots (the extreme values of
the exposure variable) for the splines, a contrast matrix was
constructed, which was multiplied with the effects estimates of the
splines. This way it is possible to predict the effect of the exposure
variables on T2DM at specified points, here every 25 g intake per
day. The effect were predicted well within the range of the original
data set as the effect estimates becomes more uncertain close to
extremes, due to the right-skewed distribution of the fish variables.
Due to the lower consumption of fatty fish in the study group, risk
ratios were only predicted up to 50 g/d compared to 75 g/d or
225 g/d for the other exposure variables.
We evaluated the effect of all exposure variables and co-variates
separately, age-adjusted and in multivariate models. The following
co-variates were explored : body mass index (BMI, assembled into
three categories: ,25 kg/m2, 25–30 kg/m2, .30 kg/m2), physi-
cal activity (recorded in the questionnaire on a scale ranging from
1 to 10 and assembled into three categories; ‘‘low’’ (1–3),
‘‘moderate’’ (4–7) and ‘‘high’’ (8–10), years of education (assem-
bled into three categories ‘‘,10 years’’, ‘‘10–12 years’’, ‘‘.12
years’’), total energy intake (kcal/d), alcohol intake (assembled into
four categories; ‘‘0 g/d’’, ‘‘1–50 g/d’’, ‘‘51–100 g/d’’, ‘‘.100 g/
d’’), smoking status (assembled into three categories; ‘‘never’’,
‘‘former’’, ‘‘current’’), self-reported hypertension (yes/no), calcu-
lated daily intake of saturated fat (g/d) and carbohydrates (g/d).
The models were also evaluated for adjustment of the various
types of fish consumed. Analysis of variance was used for assessing
whether inclusion of an extra co-variate improved the model or
not. The residual deviance was computed for the full and the
reduced model and compared. The model with lowest residual
deviance was considered having the best model fit. If there was no
significant evidence for a better model fit when including an
additional co-variate, the simplest model was preferred.
Figure 3. Risk ratios (RR) and 95% CI by fish product consumption. RRs are indicated by the solid line and the 95% CI by the dashed
horizontal lines. Numbers are adjusted for BMI, hypertension, smoking status, age and physical activity. Median intake of fish products in the study
group is indicated by the dashed vertical line.
doi:10.1371/journal.pone.0089845.g003
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Results
Fish Consumption and Risk of Type 2 Diabetes
Baseline characteristics of the total study population, the
incident T2DM cases and the non-diabetic subjects are provided
in Table 1. Mean age at enrollment was 47.9 years (min-max: 40–
55), 31.9% were current smokers and 55.2% had more than 12
years of school. The majority (65.0%) of women had BMI,25 kg/
m2. Diabetes cases were significantly different from the non-
diabetics in a number of ways: almost 80% of diabetes cases were
characterized as overweight (.25 kg/m2) or obese (.30 kg/m2).
In addition, a larger proportion of diabetes cases reported low
physical activity (22.5% vs. 11.9%), higher prevalence of
hypertension (28.6% vs. 9.3%) and more former or current
smokers than the non-diabetics. The prospective diabetes cases
were further characterized by less education, lower alcohol
consumption and slightly lower intake of total carbohydrates than
the non-diabetics at baseline.
Mean intake of total fish in the study group was 93 g/d (median
83 g/d, min-max: 0–567 g/d), dominated by intake of fish
products (mean: 37 g/d, median: 32 g/d, min-max: 0–255 g/d)
and lean fish (mean 29 g/d, median: 24 g/d, min-max: 0–244 g/
d). Mean intake of fatty fish was 15 g/d (median: 10 g/d, min-
max: 0–260 g/d). Forty-five percent of the study group used cod
liver oil supplements at least once a week.
Crude and age-adjusted risk ratios (RR) of T2DM in relation to
the exposure variables and the co-variates are listed in Table 2.
Body mass index, hypertension, physical activity, alcohol con-
sumption and smoking were strongest associated with T2DM
(Table 2).
Multivariate adjusted RR for intake of lean fish, fatty fish, fish
products, total fish, and cod liver oil supplements in relation to risk
of T2DM are illustrated in Figure 1–4 and listed in Table 3.
Consuming 75–100 g of lean fish per day, reduced the risk of
T2DM by approximately 30% (Table 3 and Figure 2). Intake of
fatty fish, fish products, total fish or cod liver oil supplement had
no effect on T2DM (Table 3, Figure 1–4).
Prevalence and Incidence of Diabetes in NOWAC
Prior to any exclusions made, the study population consisted of
48232 subjects of whom 1232 reported having DM at follow-up
(year 2002–2007). Thus, the prevalence of all forms of DM at
follow-up was 2.6%. After the exclusions, 479 incident T2DM
cases were identified in the prospective study group of 33740
subjects and 199054.4 person years. Thus, the overall incidence
rate per 1000 person years was 2.41 (95% CI: 2.20, 2.63). Figure 5
shows the incident rate of T2DM in the study population by age.
We conducted a sensitivity analyses on the incidence proportion
by excluding all subjects with missing answers on self-reported
diabetes. This way, we identified 335 incident diabetes cases in a
total study group of 24429 subjects, contributing with 144591.2
person years. Thus excluding missing answers resulted in an
incidence rate per 1000 person years of 2.32 (95% CI 2.08, 2.58).
Figure 4. Risk ratios (RR) and 95% CI by total fish consumption. RRs are indicated by the solid line and the 95% CI by the dashed horizontal
lines. Numbers are adjusted for BMI, hypertension, smoking status, age and physical activity. Median intake of total fish in the study group is
indicated by the dashed vertical line.
doi:10.1371/journal.pone.0089845.g004
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Discussion
In this national representative study group, we found a
beneficial effect of lean fish consumption on T2DM. Consumption
of 75–100 g of lean fish per day, corresponding to approximately
2.5–3 large servings per week, was associated with a reduced risk
of T2DM by close to 30%, compared to zero consumption. It is
important to emphasize that lean fish here refers to boiled or fried
whole fish or filets of cod, saithe, haddock or pollock. Processed
fish products containing lean fish as well as flour, milk and fat, had
no effect on T2DM, nor had consumption of fatty fish, total fish
intake or cod liver oil supplements.
It remains unclear whether lean fish in itself has a protective
effect on T2DM or that lean fish consumers have a protective life-
style that we were not able to take into account in the present
study. However, dietary patterns have previously been assessed in
the NOWAC cohort where fish eaters were characterized by a
high intake of lean and fatty fish and fish products, potatoes,
carrots, boiled coffee and fat and sauce for fish [23]. Additionally,
they were mainly residing in the north and west of Norway, had
lower education, were older and had higher BMI than subjects
belonging to the other dietary clusters. A large proportion was also
former or current smokers, thus, fish eaters were not immediately
characterized by a healthy lifestyle. Nevertheless, the amino acid
taurine is likely to be present in higher concentrations in cod than
in farmed salmon [24]. Taurine has showed protective effect on
CVD [25] and is suggested to have beneficial effect on the
development of metabolic syndrome and DM [26].
A protective effect from total fish consumption and intake of
small and medium sized fish was observed in Japanese men, but
not in women (median intake of 63 g/d in the second quartile of
total fish intake) [8]. The Shanghai Women’s health study reports
a beneficial effect of fish consumption among Chinese middle-aged
women (median intake of fish and shellfish ,40 g/d) [27]. Both
cohorts had a considerable lower daily intake of fish than study
subjects in the present study (median intake: 83 g/d) and none of
them distinguished between fatty and lean fish. In a large case-
cohort study across eight European countries, no effect of total fish
consumption on T2DM was observed, however they found a weak
beneficial effect of fatty fish intake [11]. In that study, the median
intake of fish and shellfish in the highest intake group were
approximately 73 g/d, thus also lower than in the present study
group. Positive associations between total fish consumption and
T2DM have been reported in three papers [5–7], two from the
United States comprising four different cohorts and one from the
Netherlands. The studies from the United States explored total fish
intake, whereas the Dutch study also evaluated fatty and lean fish
separately, but with significant result for total fish only. In the
present study, we clearly demonstrate that discriminating between
different types of fish is crucial when assessing the effect of fish
consumption on T2DM. As types of fish consumed vary across
countries, comparing total fish intake only, may lead to
misinterpretations. Cooking methods and side dishes should also
be taken into account as pointed out be Patel et al [11].
Fish, and especially fatty fish, is a considerable source of n-3
fatty acids for humans. Fatty fish also contain fat-soluble persistent
organic pollutants (POPs) which are anthropogenic compounds
that may affect human health. The fact that fatty fish is both a
source of nutrients and POPs have led to debates about the
benefits and risks of fatty fish consumption [28]. Some experi-
mental studies have raised concerns about increased risk of
metabolic syndrome and T2DM after consumption of fatty fish
due POPs [29]. We have previously demonstrated that fish and
seafood is a source of POPs for women in the NOWAC cohort,
even though only marginal differences in contaminant burden
between high and low consumers of total seafood was observed
[30,31]. It is therefore important to clearly point out that no
unfavorable effects of any kind of fish consumption or use of cod
liver oil supplements on T2DM was observed in this study. As
humans have a much more variable diet than test animals, direct
comparisons to test animals fed on a specific diet (e.g. salmon) is of
limited validity. Additionally it is important to emphasize that lean
fish has negligible concentrations of POPs in the muscles as
compared to fatty fish.
The prevalence of DM (all forms) in NOWAC was 2.6%, which
is considered low on a global scale. In the United States, the
corresponding number for women above 20 years of age is 10.8%
[32] and in Denmark the prevalence of DM among women were
4.07% in 2007 [33]. In 2004, a prevalence study of DM in Norway
was published, summarizing data from several public health
surveys [34]. Among women in the age group 40–69 years the
average prevalence varied from 1.1% to 3.2%, reflecting the same
low occurrence as found in this study. The age-adjusted overall
incidence of 2.41 per 1000 person years in the current study (mean
Table 3. Risk of T2DM in relation to fish consumption in the
study population (n = 33740).
Lean fish (g/d) RR (95% CI)a p-value
0 1.00
25 0.93 (0.71, 1.21) 0.59
50 0.82 (0.63, 1.07) 0.15
75 0.71 (0.51, 0.98) 0.04
100 0.67 (0.46, 0.98) 0.04
Fatty fish (g/d)
0 1.00
25 0.95 (0.75, 1.19) 0.63
50 1.1 (0.81, 1.50) 0.53
Fish products (g/d)
0 1.00
25 0.92 (0.60, 1.42) 0.70
50 0.89 (0.61, 1.29) 0.54
75 0.81 (0.53, 1.24) 0.34
100 0.86 (0.54, 1.38) 0.54
Total fish (g/d)
0 1.00
25 0.70 (0.47, 1.03) 0.07
50 0.58 (0.32, 1.06) 0.08
75 0.64 (0.36, 1.12) 0.12
100 0.69 (0.41, 1.16) 0.16
125 0.67 (0.39, 1.12) 0.13
150 0.65 (0.37, 1.12) 0.12
175 0.64 (0.36, 1.13) 0.12
200 0.64 (0.36, 1.16) 0.14
225 0.66 (0.36, 1.21) 0.18
Use of cod liver oil supplements
No 1.00
Yes 0.95 (0.79, 1.14) 0.56
Risk ratios (RR) and 95% confidence intervals (95% CI) are provided.
aAdjusted for age, BMI, smoking status, physical activity and hypertension.
doi:10.1371/journal.pone.0089845.t003
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age at baseline 48 years) is however similar to what has been
reported in Denmark (3.0/1000 person years for women age 50) in
2004 [33]. In this study, we treated missing information on
diabetes status as a negative answer. When conducting a sensitivity
analyses on the incidence rates and removing all subjects with
missing answers on self-reported DM, there was no significant
difference in calculated incidence rates (overlapping confidence
intervals). Additionally, results from our validation study suggest
that missing answer on diabetes status can be interpreted as a
negative response. This is further supported by a test-retest study
on disease reproducibility in NOWAC (un-published data). We
therefore considered the risk of overestimation of T2DM cases in
the prospective analyses as very limited.
The aim of the cross-sectional validation study was to evaluate
the positive predictive value of the NOWAC questionnaire in
regards to T2DM. For all forms of DM the PPV were 93%, which
we consider good. For T2DM the corresponding number was
84%. Thus, there was a 16% risk of overestimating T2DM cases,
where 8% corresponded to T1DM. Including a pre-defined
criteria of age at diagnosis .35 years will not improve the PPV as
the self-reported mean age at time for diagnosis were 44 years
among those claiming having T1DM and 48 years for T2DM
cases. In a prospective setting the percentage of misclassification/
overestimation of T2DM cases are likely to be less than obtained
in this cross-sectional study as more than one questionnaire is
available and prevalent cases at baseline can be excluded.
Additionally we found that T2DM comprised 89% of DM, which
is in line with previous findings worldwide [35]. We conclude that
in the NOWAC study which comprise middle-aged women only, a
positive answer on self-reported diabetes are likely to reflect
T2DM. In order to identify T1DM cases, contact with the subjects
GP is necessary.
The NOWAC study is a national representative cohort, which
brings the advantage of incidence and prevalence calculations.
Additionally, the NOWAC FFQ contains detailed information on
various types of fish consumed, which generates a trustworthy
measure of exposure. There are however a few limitations with the
present study; we had no information about family history of
diabetes and was not able to adjust the analyses for that risk factor.
Furthermore, we had no ascertainment that those subjects
reporting not having diabetes actually did not have the disease.
The detailed FFQ on fish consumption may increase the risk of
over-reporting fish intake.
Conclusion
Lean fish consumption of 75–100 g/d had a beneficial effect on
T2DM. Unfavorable effects of fatty fish consumption or use of cod
liver oil supplements on T2DM were not observed.
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